Defining “Complete Cytoreduction” After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis-Reference-Cited by-同舟云学术

Defining “Complete Cytoreduction” After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis

Published:2020-07-23 Issue:13 Volume:27 Page:5026-5036
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Munoz-Zuluaga Carlos A.^ORCID,King Mary C.^ORCID,Diaz-Sarmiento Victor S.,Studeman Kimberley,Sittig Michelle^ORCID,MacDonald Ryan,Nieroda Carol,Zambrano-Vera Katherin^ORCID,Gushchin Vadim^ORCID,Sardi Armando^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-020-08844-5.pdf

Reference29 articles.

1. Bradley RF, Carr NJ. Pseudomyxoma peritonei: pathology, a historical overview, and proposal for unified nomenclature and updated grading. AJSP Rev Rep. 2019;24(3):88–93.

2. Munoz-Zuluaga C, King MC, Sardi A, et al. Selection and characteristics of patients with peritoneal dissemination from appendiceal cancer with exceptional/poor survival after CRS/HIPEC. Ann Surg Oncol. 2019;26:2268–75.

3. Zambrano-Vera K, Sardi A, Munoz-Zuluaga C, et al. Outcomes in peritoneal carcinomatosis from appendiceal goblet cell carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Ann Surg Oncol. 2020;27(1):179–87.

4. Zhang K, Meyerson C, Kassardjian A, Westbrook LM, Zheng W, Wang HL. Goblet cell carcinoid/carcinoma: an update. Adv Anatomic Pathol. 2019;26(2):75–83.

5. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7(1):69–76.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between preoperative cardiopulmonary exercise testing and six-minute walk test, five-times sit to stand test and Short Form-36 physical component score in patients undergoing cytoreductive surgery;Surgical Oncology Insight;2024-06

2. Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers;JCO Precision Oncology;2024-05

3. Outcomes following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies: 10 Year experience;The American Journal of Surgery;2024-04

4. Peritonealkarzinose und Erkrankungen des Peritoneums;Springer Reference Medizin;2024

5. Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2023-08-26